Description

tert-Butyl (2-(2-(4-Fluorophenyl)-8,8-Dimethyl-5,6-Dihydroimidazo[1,2-A]Pyrazin-7(8H)-Yl)-2-Oxoethyl)Carbamate is a sophisticated heterocyclic building block and pharmaceutical intermediate of significant interest in modern organic synthesis. This compound matters for its role as a key precursor in the development of novel active pharmaceutical ingredients (APIs), particularly those targeting neurological and oncological pathways. Pharmaceutical R&D teams, contract research organizations (CROs), and advanced fine chemical manufacturers are the primary users who need this high-purity intermediate to accelerate their drug discovery and process development programs.

Application

• Pharmaceutical Intermediate: Critical building block for the synthesis of novel drug candidates, particularly in medicinal chemistry research.
• API Synthesis: Used in the development and scale-up of Active Pharmaceutical Ingredients (APIs) targeting specific receptors.
• Biochemical Research: Serves as a tool compound or precursor in biochemical assays and pharmacological studies.
• Process Chemistry: Employed in route scouting and optimization for the efficient manufacturing of complex molecules.
• Custom Synthesis: A starting material for the contract manufacturing of specialized, non-commercial compounds for client-specific projects.
• Library Synthesis: Used to generate focused libraries of analogs for structure-activity relationship (SAR) studies in drug discovery.

Basic Information

Item	Details
Product Name	tert-Butyl (2-(2-(4-Fluorophenyl)-8,8-Dimethyl-5,6-Dihydroimidazo[1,2-A]Pyrazin-7(8H)-Yl)-2-Oxoethyl)Carbamate
CAS No.	1261118-05-1
Molecular Formula	C21H27FN4O3
Molecular Weight	402.47 g/mol
Synonyms	Boc-protected imidazopyrazine fluorophenyl derivative; 7-[2-[(tert-Butoxycarbonyl)amino]-1-oxoethyl]-2-(4-fluorophenyl)-8,8-dimethyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine; tert-Butyl N-[2-[2-(4-fluorophenyl)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl]-2-oxoethyl]carbamate; UNII-7K4I8P454Q; 1261118-05-1; Imidazo[1,2-a]pyrazine intermediate; Fluorophenyl imidazopyrazine carbamate.
EINECS	Contact for details

Quality Control

Our tert-Butyl (2-(2-(4-Fluorophenyl)-8,8-Dimethyl-5,6-Dihydroimidazo[1,2-A]Pyrazin-7(8H)-Yl)-2-Oxoethyl)Carbamate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing purity, impurities, and other critical parameters are provided with every shipment and are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.